发明名称 FORMULATION AND DOSAGE FORM FOR INCREASING ORAL BIOAVAILABILITY OF HYDROPHILIC MACROMOLECULES
摘要 The present invention includes a formulation and dosage form for enhancing t he bioavailability of orally administered hydrophilic macromolecules. The formulation of the present invention includes a permeation enhancer, a hydrophilic macromolecule, and a carrier that exhibits in-situ gelling properties, such as nonionic surfactant. The formulation of the present invention is delivered within the GI tract as a liquid having at least some affinity for the surface of the GI mucosal membrane. Once released, it is believed that the liquid formulation spreads across one or more areas of the surface of the GI mucosal membrane, where the carrier of the formulation the n transitions into a biodhesive gel in-situ. As a bioadhesive gel, the formulation of the present invention present the hydrophilic macromolecule a nd the permeation enhancer at the surface of the GI mucosal membrane at concentrations sufficient to increase absorption of the hydrophilic macromolecule through the GI mucosal membrane over a period of time. The dosage form of the present invention incorporates the formulation of the present invention and may be designed to provide the controlled release of t he formulation within the GI tract over a desired period of time.
申请公布号 CA2471096(A1) 申请公布日期 2003.07.03
申请号 CA20022471096 申请日期 2002.12.18
申请人 ALZA CORPORATION 发明人 YUM, SI-HONG;CHAO, ANTHONY C.;DONG, LIANG C.;NGUYEN, VU A.;DADDONA, PETER E.;WONG, PATRICK S., L.
分类号 A61K47/34;A61K9/00;A61K9/127;A61K9/48;A61K31/715;A61K31/727;A61K38/00;A61K38/04;A61K38/21;A61K38/22;A61K38/23;A61K38/27;A61K38/28;A61K38/43;A61K38/55;A61K47/02;A61K47/10;A61K47/12;A61K47/14;A61K47/18;A61K47/22;A61K47/28;A61P7/04;A61P9/08;A61P9/10;A61P13/10;A61P13/12;(IPC1-7):A61K9/00;A61K38/16 主分类号 A61K47/34
代理机构 代理人
主权项
地址